Company
Abbott Laboratories ABT
Tracked across 20 disclosed holders on Protégé.
9 tracked investors, latest 13F quarter ending 30 Jun 2026 · 10 members of Congress · 1 executive · latest filing 12 Oct 2026
Held by these investors
| Investor | Weight in portfolio | Value (13F) | Quarter ending |
|---|---|---|---|
| Hudson Bay Capital Management | 0.8% | $145.2M | 2026-06-30 |
| Two Sigma Investments | 0.6% | $737.4M | 2026-06-30 |
| Holocene Advisors | 0.5% | $226.0M | 2026-06-30 |
| Ken Griffin | 0.5% | $780.1M | 2026-06-30 |
| Marshall Wace | 0.4% | $502.9M | 2026-06-30 |
| Adage Capital Management | 0.3% | $211.6M | 2026-06-30 |
| Tudor Investment Corporation | 0.3% | $66.3M | 2026-06-30 |
| Israel Englander | 0.2% | $326.7M | 2026-06-30 |
| Element Capital Management | 0.1% | $2.0M | 2026-06-30 |
Members of Congress who disclosed trades
| Politician | Disclosed activity | Est. net |
|---|---|---|
| Rick Allen | 0 buys / 2 sells | -$65K |
| Byron Donalds | 0 buys / 2 sells | -$16K |
| Richard McCormick | 3 buys / 1 sell | $16K |
| Julie Johnson | 0 buys / 2 sells | -$16K |
| Josh Gottheimer | 0 buys / 1 sell | -$8K |
| Mike Kelly | 0 buys / 1 sell | -$8K |
| Thomas Kean | 1 buy / 0 sells | $8K |
| Rick Larsen | 0 buys / 1 sell | -$8K |
| Gilbert Cisneros | 2 buys / 2 sells | $0 |
| Laura Friedman | 0 buys / 0 sells | $0 |
Company executives who disclosed trades
| Executive | Disclosed activity | Net |
|---|---|---|
| Robert Ford | 1 buy / 2 sells | -$81.6M |
Sources: SEC EDGAR (Form 13F-HR and Form 4) and the official House and Senate STOCK Act disclosures. Filings are quarterly or delayed, so current holdings may differ. Weights are each holder's own portfolio share, not a share of the company.